NovaBay Pharmaceuticals Stock Quote NBY - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

2.13

Bid

Ask

Volume

0.00 Day's Range 0.00

2.0501 52 Week Range 44.80

Market Cap

2.453M

Previous Close

2.13

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

9,415,221

Shares Outstanding

1,151,715

Dividend Yield

PE Ratio

-0.15

Earnings Per Share (EPS)

-14.5

Revenue

14.73M

Net Profit

-16.7M

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare and skincare products. Its leading product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is proven in laboratory testing to have broad antimicrobial... NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare and skincare products. Its leading product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is proven in laboratory testing to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available direct to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.novabay.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

NovaBay Pharmaceuticals Inc New is listed in the Pharmaceutical Preparations sector of the American Stock Exchange with ticker NBY. The last closing price for NovaBay Pharmaceuticals was $2.13. Over the last year, NovaBay Pharmaceuticals shares have traded in a share price range of $ 2.0501 to $ 44.80.

NovaBay Pharmaceuticals currently has 1,151,715 shares outstanding. The market capitalization of NovaBay Pharmaceuticals is $2.45 million. NovaBay Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.15.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.1	-4.48430493274	2.23	2.27	2.1	25522	2.15416891	CS
4	-0.7	-24.7349823322	2.83	3.14	2.0501	140785	2.42682202	CS
12	-0.7365	-25.6933542648	2.8665	9.079	2.0501	9415221	4.76737473	CS
26	-4.87	-69.5714285714	7	9.079	2.0501	6141686	4.96196311	CS
52	-21.0575	-90.8140161725	23.1875	44.8	2.0501	3391640	6.60998246	CS
156	-766.0675	-99.7227275538	768.1975	943.25	2.0501	1674266	147.91252035	CS
260	-1957.87	-99.8913265306	1960	2670.5	2.0501	2056113	736.511129	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WENAANEW MEDICAL INC	$ 2.56 (76.55%)	3.17M
PEGYPineapple Energy Inc	$ 2.055 (71.25%)	7.05M
ZAPPZapp Electric Vehicles Group Ltd	$ 13.11 (41.88%)	1.4M
BTCSBTCS Inc	$ 1.63 (16.43%)	160
SVMHSRIVARU Holding Ltd	$ 0.2202 (15.89%)	1.89M
INDVIndivior PLC	$ 9.56 (-37.68%)	75.61k
SHPWShapeways Holdings Inc	$ 0.3756 (-22.97%)	214.07k
TXMDTherapeuticsMD Inc	$ 1.38 (-18.84%)	24
GNLNGreenlane Holdings Inc	$ 0.2352 (-18.67%)	1.44M
TNXPTonix Pharmaceuticals Holding Corporation	$ 0.5945 (-16.55%)	76.52k
MAXNMaxeon Solar Technologies Ltd	$ 0.2709 (0.33%)	7.15M
PEGYPineapple Energy Inc	$ 2.055 (71.25%)	7.05M
MYNZMainz BioMed NV	$ 0.527 (10.48%)	5.55M
WENAANEW MEDICAL INC	$ 2.56 (76.55%)	3.17M
SVMHSRIVARU Holding Ltd	$ 0.2202 (15.89%)	1.89M